We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Hutchmed (china) Limited | LSE:HCM | London | Ordinary Share | KYG4672N1198 | ORD USD0.10 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -14.00 | -4.61% | 290.00 | 289.00 | 291.00 | 312.00 | 287.00 | 312.00 | 85,819 | 16:22:23 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 838M | 100.78M | - | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMHCM
RNS Number : 2713N
Hutchison China Meditech Limited
07 August 2017
Directors' Share Dealing
London: Monday, August 7, 2017: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) has received notifications that:-
(a) Mr Simon To, Executive Director and Chairman, through Dynamic Drive Limited, a person closely associated ("PCA") with Mr To, purchased a total of 1,748 American Depositary Shares of the Company ("ADSs", each representing one half of one ordinary share of US$1.00 each in the capital of Chi-Med ("Ordinary Share")) on August 2, 2017 at a price of US$22.97 per ADS. Dynamic Drive Limited is controlled by the trustee of Dynamic Drive Trust (the "DDT") which has been established for the benefit of Mr To's family members, of which Mr To is the settlor;
(b) Mr To through Wencheng Capital Limited ("WCL"), a PCA with Mr To, purchased a total of 1,826 ADSs between August 2 and August 3, 2017 at an average price of US$22.93 per ADS. WCL is controlled by the trustee of Wencheng Trust ("WT") which has been established for the benefit of Mr To's family member, of which Mr To is the settlor;
(c) Mr Paul Carter, Independent Non-executive Director, purchased a total of 724 Ordinary Shares at a price of GBP34.25 per share on August 2, 2017;
(d) Dr Dan Eldar, Non-executive Director, purchased a total of 1,900 Ordinary Shares at an average price of GBP34.93 per share on August 2, 2017;
(e) Dr Karen Ferrante, Independent Non-executive Director, purchased a total of 3,245 ADSs at an average price of US$22.94 per ADS on August 2, 2017; and
(f) Ms Edith Shih, Non-executive Director and Company Secretary, purchased a total of 7,712 ADSs and 10,000 Ordinary Shares at an average price of US$23.29 per ADS and GBP34.75 per share respectively between August 3 and August 4, 2017.
Following the above purchases, (i) Mr To is interested in 110,401 ADSs (in DDT and WT of which his family members are the beneficiaries) and 180,000 Ordinary Shares (including the holding of 78,000 Ordinary Shares in DDT of which his family members are the beneficiaries), representing in aggregate approximately 0.39% of the current issued share capital of Chi-Med; (ii) Mr Carter is interested in 3,524 Ordinary Shares, representing approximately 0.006% of the current issued share capital of Chi-Med; (iii) Dr Eldar is interested in 1,900 Ordinary Shares and 6,225 ADSs, representing approximately 0.008% of the current issued share capital of Chi-Med; (iv) Dr Ferrante is interested in 5,785 ADSs, representing approximately 0.005% of the current issued share capital of Chi-Med; and (v) Ms Shih is interested in 83,856 ADSs and 70,000 Ordinary Shares, representing approximately 0.18% of the current issued share capital of Chi-Med.
The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.
(a) Dynamic Drive Limited
Hot Features
Premium
1 Details of the person discharging managerial responsibilities/person closely associated
----- ---------------------------------------------------------------------------------------------------------------
a) Name Dynamic Drive Limited
----- ------------------------------------ -------------------------------------------------------------------------
2 Reason for the notification
----- ---------------------------------------------------------------------------------------------------------------
a) Position/status Person closely associated with Mr Simon To, Executive Director and
Chairman. Dynamic Drive
Limited is controlled by the trustee of Dynamic Drive Trust which has
been established for
the benefit of Mr To's family members, of which Mr To is the settlor.
----- ------------------------------------ -------------------------------------------------------------------------
b) Initial notification/Amendment Initial notification
----- ------------------------------------ -------------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
----- ---------------------------------------------------------------------------------------------------------------
a) Name Hutchison China MediTech Limited
----- ------------------------------------ -------------------------------------------------------------------------
b) LEI 2138006X34YDQ6OBYE79
----- ------------------------------------ -------------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
----- ---------------------------------------------------------------------------------------------------------------
a) Description of the financial ADS each representing one half of one Ordinary Share of US$1.00
instrument, type of instrument ADS ISIN: US44842L1035
Identification code
----- ------------------------------------ -------------------------------------------------------------------------
b) Nature of the transaction Acquisition of 1,748 ADSs in the name of Dynamic Drive Limited which
holds the ADSs for a
family trust (Dynamic Drive Trust) of which Mr To is the settlor on
August 2, 2017 at a price
of US$22.97 per ADS.
----- ------------------------------------ -------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----- ------------------------------------ ------------------------------------ -----------------------------------
US$22.97 1,748
------------------------------------------------------------------------------- -----------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
----- ------------------------------------ -------------------------------------------------------------------------
e) Date of the transaction 2017-08-02
----- ------------------------------------ -------------------------------------------------------------------------
f) Place of the transaction Nasdaq Stock Market
----- ------------------------------------ -------------------------------------------------------------------------
(b) Wencheng Capital Limited
1 Details of the person discharging managerial responsibilities/person closely associated
----- ---------------------------------------------------------------------------------------------------------------
a) Name Wencheng Capital Limited
----- ------------------------------------ -------------------------------------------------------------------------
2 Reason for the notification
----- ---------------------------------------------------------------------------------------------------------------
a) Position/status Person closely associated with Mr Simon To, Executive Director and
Chairman. Wencheng Capital
Limited is controlled by the trustee of Wencheng Trust which has been
established for the
benefit of Mr To's family members, of which Mr To is the settlor.
----- ------------------------------------ -------------------------------------------------------------------------
b) Initial notification/Amendment Initial notification
----- ------------------------------------ -------------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
----- ---------------------------------------------------------------------------------------------------------------
a) Name Hutchison China MediTech Limited
----- ------------------------------------ -------------------------------------------------------------------------
b) LEI 2138006X34YDQ6OBYE79
----- ------------------------------------ -------------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
----- ---------------------------------------------------------------------------------------------------------------
a) Description of the financial ADS each representing one half of one Ordinary Share of US$1.00
instrument, type of instrument ADS ISIN: US44842L1035
Identification code
----- ------------------------------------ -------------------------------------------------------------------------
b) Nature of the transaction Acquisition of 1,826 ADSs in the name of Wencheng Capital Limited which
holds the ADSs for
a family trust (Wencheng Trust) of which Mr To is the settlor between
August 2 and 3, 2017
at an average price of US$22.93 per ADS.
----- ------------------------------------ -------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----- ------------------------------------ ------------------------------------ -----------------------------------
US$22.93 1,726
------------------------------------------------------------------------------- -----------------------------------
US$22.95 100
------------------------------------------------------------------------------- -----------------------------------
d) Aggregated information Aggregated volume: 1,826
- Aggregated volume Price information: US$22.93
- Price
----- ------------------------------------ -------------------------------------------------------------------------
e) Date of the transaction 2017-08-02 - acquisition of 1,726 ADSs
2017-08-03 - acquisition of 100 ADSs
----- ------------------------------------ -------------------------------------------------------------------------
f) Place of the transaction Nasdaq Stock Market
----- ------------------------------------ -------------------------------------------------------------------------
(c) Mr Paul Carter
1 Details of the person discharging managerial responsibilities/person closely associated
----- ---------------------------------------------------------------------------------------------------------------
a) Name Mr Paul Carter
----- ------------------------------------ -------------------------------------------------------------------------
2 Reason for the notification
----- ---------------------------------------------------------------------------------------------------------------
a) Position/status Independent Non-executive Director
----- ------------------------------------ -------------------------------------------------------------------------
b) Initial notification/Amendment Initial notification
----- ------------------------------------ -------------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
----- ---------------------------------------------------------------------------------------------------------------
a) Name Hutchison China MediTech Limited
----- ------------------------------------ -------------------------------------------------------------------------
b) LEI 2138006X34YDQ6OBYE79
----- ------------------------------------ -------------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
----- ---------------------------------------------------------------------------------------------------------------
a) Description of the financial Ordinary Share of US$1.00 each
instrument, type of instrument DI ISIN: KYG4672N1016
Identification code
----- ------------------------------------ -------------------------------------------------------------------------
b) Nature of the transaction Acquisition of 724 Ordinary Shares on August 2, 2017 at a price of
GBP34.25 per share.
----- ------------------------------------ -------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----- ------------------------------------ ------------------------------------ -----------------------------------
GBP34.25 724
------------------------------------------------------------------------------- -----------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
----- ------------------------------------ -------------------------------------------------------------------------
e) Date of the transaction 2017-08-02
----- ------------------------------------ -------------------------------------------------------------------------
f) Place of the transaction London Stock Exchange (XLON)
----- ------------------------------------ -------------------------------------------------------------------------
(d) Dr Dan Eldar
1 Details of the person discharging managerial responsibilities/person closely associated
----- ---------------------------------------------------------------------------------------------------------------
a) Name Dr Dan Eldar
----- ------------------------------------ -------------------------------------------------------------------------
2 Reason for the notification
----- ---------------------------------------------------------------------------------------------------------------
a) Position/status Non-executive Director
----- ------------------------------------ -------------------------------------------------------------------------
b) Initial notification/Amendment Initial notification
----- ------------------------------------ -------------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
----- ---------------------------------------------------------------------------------------------------------------
a) Name Hutchison China MediTech Limited
----- ------------------------------------ -------------------------------------------------------------------------
b) LEI 2138006X34YDQ6OBYE79
----- ------------------------------------ -------------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
----- ---------------------------------------------------------------------------------------------------------------
a) Description of the financial Ordinary Share of US$1.00 each
instrument, type of instrument DI ISIN: KYG4672N1016
Identification code
----- ------------------------------------ -------------------------------------------------------------------------
b) Nature of the transaction Acquisition of 1,900 Ordinary Shares on August 2, 2017 at an average
price of GBP34.93 per
share.
----- ------------------------------------ -------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----- ------------------------------------ ------------------------------------ -----------------------------------
GBP34.50 250
------------------------------------------------------------------------------- -----------------------------------
GBP35.00 1,650
------------------------------------------------------------------------------- -----------------------------------
d) Aggregated information Aggregated volume: 1,900
- Aggregated volume Price information: GBP34.93
- Price
----- ------------------------------------ -------------------------------------------------------------------------
e) Date of the transaction 2017-08-02
----- ------------------------------------ -------------------------------------------------------------------------
f) Place of the transaction London Stock Exchange (XLON)
----- ------------------------------------ -------------------------------------------------------------------------
(e) Dr Karen Ferrante
1 Details of the person discharging managerial responsibilities/person closely associated
----- ---------------------------------------------------------------------------------------------------------------
a) Name Dr Karen Ferrante
----- ------------------------------------ -------------------------------------------------------------------------
2 Reason for the notification
----- ---------------------------------------------------------------------------------------------------------------
a) Position/status Independent Non-executive Director
----- ------------------------------------ -------------------------------------------------------------------------
b) Initial notification/Amendment Initial notification
----- ------------------------------------ -------------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
----- ---------------------------------------------------------------------------------------------------------------
a) Name Hutchison China MediTech Limited
----- ------------------------------------ -------------------------------------------------------------------------
b) LEI 2138006X34YDQ6OBYE79
----- ------------------------------------ -------------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
----- ---------------------------------------------------------------------------------------------------------------
a) Description of the financial ADS each representing one half of one Ordinary Share of US$1.00
instrument, type of instrument ADS ISIN: US44842L1035
Identification code
----- ------------------------------------ -------------------------------------------------------------------------
b) Nature of the transaction Acquisition of 3,245 ADSs on August 2, 2017 at an average price of
US$22.94 per ADS.
----- ------------------------------------ -------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----- ------------------------------------ ------------------------------------ -----------------------------------
US$22.74 200
------------------------------------------------------------------------------- -----------------------------------
US$22.75 800
------------------------------------------------------------------------------- -----------------------------------
US$22.78 270
------------------------------------------------------------------------------- -----------------------------------
US$22.86 100
------------------------------------------------------------------------------- -----------------------------------
US$22.88 300
------------------------------------------------------------------------------- -----------------------------------
US$22.90 100
------------------------------------------------------------------------------- -----------------------------------
US$23.12 1,475
------------------------------------------------------------------------------- -----------------------------------
d) Aggregated information Aggregated volume: 3,245
- Aggregated volume Price information: US$22.94
- Price
----- ------------------------------------ -------------------------------------------------------------------------
e) Date of the transaction 2017-08-02
----- ------------------------------------ -------------------------------------------------------------------------
f) Place of the transaction Nasdaq Stock Market
----- ------------------------------------ -------------------------------------------------------------------------
(f) Ms Edith Shih
1 Details of the person discharging managerial responsibilities/person closely associated
----- ---------------------------------------------------------------------------------------------------------------
a) Name Ms Edith Shih
----- ------------------------------------ -------------------------------------------------------------------------
2 Reason for the notification
----- ---------------------------------------------------------------------------------------------------------------
a) Position/status Non-executive Director and Company Secretary
----- ------------------------------------ -------------------------------------------------------------------------
b) Initial notification/Amendment Initial notification
----- ------------------------------------ -------------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
----- ---------------------------------------------------------------------------------------------------------------
a) Name Hutchison China MediTech Limited
----- ------------------------------------ -------------------------------------------------------------------------
b) LEI 2138006X34YDQ6OBYE79
----- ------------------------------------ -------------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
----- ---------------------------------------------------------------------------------------------------------------
a) Description of the financial ADS each representing one half of one Ordinary Share of US$1.00/
instrument, type of instrument Ordinary Share of US$1.00
Identification code each
ADS ISIN: US44842L1035/ DI ISIN: KYG4672N1016
----- ------------------------------------ -------------------------------------------------------------------------
b) Nature of the transaction Acquisition of 7,712 ADSs and 10,000 Ordinary Shares between August 3
and August 4, 2017 at
an average price of US$23.29 per ADS and GBP34.75 per share
respectively.
----- ------------------------------------ -------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----- ------------------------------------ ------------------------------------ -----------------------------------
US$23.30 6,112
------------------------------------------------------------------------------- -----------------------------------
US$23.29 800
------------------------------------------------------------------------------- -----------------------------------
US$23.27 100
------------------------------------------------------------------------------- -----------------------------------
US$23.22 200
------------------------------------------------------------------------------- -----------------------------------
US$23.20 100
------------------------------------------------------------------------------- -----------------------------------
US$23.19 400
------------------------------------------------------------------------------- -----------------------------------
GBP34.75 10,000
------------------------------------------------------------------------------- -----------------------------------
d) Aggregated information Aggregated volume: 7,712 ADSs and 10,000 Ordinary Shares
- Aggregated volume Price information: US$23.29/ GBP34.75
- Price
----- ------------------------------------ -------------------------------------------------------------------------
e) Date of the transaction 2017-08-03 - acquisition of 7,712 ADSs
2017-08-04 - acquisition of 10,000 Ordinary Shares
----- ------------------------------------ -------------------------------------------------------------------------
f) Place of the transaction Nasdaq Stock Market/ London Stock Exchange (XLON)
----- ------------------------------------ -------------------------------------------------------------------------
About Chi-Med
Chi-Med is an innovative biopharmaceutical company which researches, develops, manufactures and sells pharmaceuticals and healthcare products. Its Innovation Platform, Hutchison MediPharma Limited, focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases for the global market. Its Commercial Platform manufactures, markets, and distributes prescription drugs and consumer health products in China.
Chi-Med is majority owned by the multinational conglomerate CK Hutchison Holdings Limited ("CK Hutchison") (SEHK: 0001). For more information, please visit: www.chi-med.com.
CONTACTS
Investor Enquiries Mark Lee, SVP Corporate Finance & Development +852 2121 8200 U.K. & International Media Enquiries Anthony Carlisle, Citigate Dewe Rogerson +44 7973 611 888 (Mobile) anthony.carlisle@cdrconsultancy.co.uk U.S. Based Media Enquiries Brad Miles, BMC Communications +1 (917) 570 7340 (Mobile) bmiles@bmccommunications.com Susan Duffy, BMC Communications +1 (917) 499 8887 (Mobile) sduffy@bmccommunications.com Investor Relations Matt Beck, The Trout Group +1 (917) 415 1750 (Mobile) mbeck@troutgroup.com David Dible, Citigate Dewe Rogerson +44 7967 566 919 (Mobile) david.dible@citigatedr.co.uk Panmure Gordon (UK) Limited Richard Gray / Andrew Potts +44 (20) 7886 2500
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLIFVTTFIDIID
(END) Dow Jones Newswires
August 07, 2017 04:45 ET (08:45 GMT)
1 Year Hutchmed (china) Chart |
1 Month Hutchmed (china) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
